Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Auclair

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 22, 2010
F15599, a preferential post-synaptic 5-HT1A receptor agonist: activity in models of cognition in comparison with reference 5-HT1A receptor agonistsRonan Depoortère, Agnès L Auclair, Laurent Bardin, et al.
Oral Surgery, Oral Medicine, and Oral Pathology|November 1, 1990
Diagnosis of oral hairy leukoplakia by ultrastructural examination of exfoliative cytologic specimensF J Kratochvil, G P Riordan, P L Auclair, et al.
Journal of the American College of Cardiology|April 13, 2001
Randomized trial of a noninvasive strategy to reduce hospital stay for patients with low-risk myocardial infarctionP Bogaty, S Dumont, G E O'Hara, et al.
Urology|April 1, 1982
Unusual case of dysgenetic renal cystP J Christenson, M A Clark, J Meek, et al.
Behavioural Brain Research|May 26, 2009
Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeysAgnès L Auclair, Mark S Kleven, Catherine Barret-Grévoz, et al.
Journal of Neurochemistry|June 11, 2010
The central serotonin 2B receptor: a new pharmacological target to modulate the mesoaccumbens dopaminergic pathway activityAgnès L Auclair, Adeline Cathala, Frédéric Sarrazin, et al.
Neuropsychologia|September 13, 2005
Deficit of preparatory attention in children with frontal lobe epilepsyL Auclair, Isabelle Jambaqué, Jambaqué Isabelle, et al.
British Journal of Pharmacology|March 22, 2007
F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophreniaR Depoortère, L Bardin, A L Auclair, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|September 30, 1999
P53 and cyclin D1 staining patterns of malignant and premalignant oral lesions in age-dependent populationsJ T Castle, M Cardinali, F J Kratochvil, et al.
British Journal of Pharmacology|March 22, 2007
F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptomsR Depoortère, A L Auclair, L Bardin, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 22, 2010
F15599, a preferential post-synaptic 5-HT1A receptor agonist: activity in models of cognition in comparison with reference 5-HT1A receptor agonistsRonan Depoortère, Agnès L Auclair, Laurent Bardin, et al.
Oral Surgery, Oral Medicine, and Oral Pathology|November 1, 1990
Diagnosis of oral hairy leukoplakia by ultrastructural examination of exfoliative cytologic specimensF J Kratochvil, G P Riordan, P L Auclair, et al.
Journal of the American College of Cardiology|April 13, 2001
Randomized trial of a noninvasive strategy to reduce hospital stay for patients with low-risk myocardial infarctionP Bogaty, S Dumont, G E O'Hara, et al.
Urology|April 1, 1982
Unusual case of dysgenetic renal cystP J Christenson, M A Clark, J Meek, et al.
Behavioural Brain Research|May 26, 2009
Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeysAgnès L Auclair, Mark S Kleven, Catherine Barret-Grévoz, et al.
Journal of Neurochemistry|June 11, 2010
The central serotonin 2B receptor: a new pharmacological target to modulate the mesoaccumbens dopaminergic pathway activityAgnès L Auclair, Adeline Cathala, Frédéric Sarrazin, et al.
Neuropsychologia|September 13, 2005
Deficit of preparatory attention in children with frontal lobe epilepsyL Auclair, Isabelle Jambaqué, Jambaqué Isabelle, et al.
British Journal of Pharmacology|March 22, 2007
F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophreniaR Depoortère, L Bardin, A L Auclair, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|September 30, 1999
P53 and cyclin D1 staining patterns of malignant and premalignant oral lesions in age-dependent populationsJ T Castle, M Cardinali, F J Kratochvil, et al.
British Journal of Pharmacology|March 22, 2007
F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptomsR Depoortère, A L Auclair, L Bardin, et al.
Pageof 5